← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

EUDA Health Holdings Limited (EUDA) 10-Year Financial Performance & Capital Metrics

EUDA • • Industrial / General
HealthcareHealthcare ITTelehealth & Virtual Care PlatformsGeneral Telehealth Platforms
AboutEUDA Health Limited develops digital health platform that offers virtual consults for non-emergency medical issues. The company was founded in 2019 and is based in Singapore. EUDA Health Limited company operates as a subsidiary of Watermark Developments Limited.Show more
  • Revenue $4M +8.2%
  • EBITDA -$17M -345.8%
  • Net Income -$15M -53.0%
  • EPS (Diluted) -0.47 -6.8%
  • Gross Margin 19% -16.4%
  • EBITDA Margin -427.87% -311.9%
  • Operating Margin -432.19% -304.4%
  • Net Margin -382.87% -41.4%
  • ROE -
  • ROIC -
  • Debt/Equity -
  • Interest Coverage -386.17 -126.4%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Efficient asset utilization: 2.3x turnover

✗Weaknesses

  • ✗Weak Piotroski F-Score: 3/9
  • ✗Negative free cash flow
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Shares diluted 41.7% in last year
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y-
3Y-4.18%
TTM30.08%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM101.13%

EPS CAGR

10Y-
5Y-
3Y-
TTM93.81%

ROCE

10Y Avg-541.56%
5Y Avg-541.56%
3Y Avg-913.9%
Latest-

Peer Comparison

General Telehealth Platforms
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
AMWLAmerican Well Corporation70.09M4.76-0.34-1.81%-42.8%-42.43%0.03
TDOCTeladoc Health, Inc.1.16B6.53-1.11-1.26%-8.84%-16.06%24.41%1.06
EUDAEUDA Health Holdings Limited69.19M1.83-3.898.22%5.17%

Profit & Loss

Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+8.88M4.56M3.76M3.71M4.01M
Revenue Growth %--0.49%-0.17%-0.02%0.08%
Cost of Goods Sold+4.99M3.31M2.89M2.86M3.25M
COGS % of Revenue0.56%0.73%0.77%0.77%0.81%
Gross Profit+3.89M1.25M870K842.08K762.15K
Gross Margin %0.44%0.27%0.23%0.23%0.19%
Gross Profit Growth %--0.68%-0.3%-0.03%-0.09%
Operating Expenses+4.78M1.81M13.09M4.8M18.1M
OpEx % of Revenue0.54%0.4%3.48%1.3%4.51%
Selling, General & Admin4.63M1.81M6.75M4.8M3.34M
SG&A % of Revenue0.52%0.4%1.79%1.3%0.83%
Research & Development158.01K129.26K17.21K00
R&D % of Revenue0.02%0.03%0%--
Other Operating Expenses0-129.26K6.32M014.76M
Operating Income+-893.56K-559.99K-5.72M-3.96M-17.34M
Operating Margin %-0.1%-0.12%-1.52%-1.07%-4.32%
Operating Income Growth %-0.37%-9.21%0.31%-3.38%
EBITDA+-669.44K-295.89K-5.46M-3.85M-17.16M
EBITDA Margin %-0.08%-0.06%-1.45%-1.04%-4.28%
EBITDA Growth %-0.56%-17.46%0.3%-3.46%
D&A (Non-Cash Add-back)224.12K264.1K256.26K111.2K173.22K
EBIT-893.56K1.08M-24.81M-8.41M-17.6M
Net Interest Income+-65.82K1.79M-93.78K-23.23K-44.89K
Interest Income01.92M000
Interest Expense65.82K127.13K93.78K23.23K44.89K
Other Income/Expense1.14M2.23M-19.21M-4.47M-307.38K
Pretax Income+246.45K1.67M-24.93M-8.43M-17.64M
Pretax Margin %0.03%0.37%-6.62%-2.28%-4.4%
Income Tax+47.48K46.49K-20.79K0-4.38K
Effective Tax Rate %0.71%0.52%1%1.19%0.87%
Net Income+175.57K864.83K-24.88M-10.04M-15.36M
Net Margin %0.02%0.19%-6.61%-2.71%-3.83%
Net Income Growth %-3.93%-29.77%0.6%-0.53%
Net Income (Continuing)198.97K1.62M-25.01M-8.43M-17.64M
Discontinued Operations0-722.44K58.66K-1.6M2.25M
Minority Interest43.23K78.82K13.48K16.61K-19.01K
EPS (Diluted)+0.020.09-2.07-0.44-0.47
EPS Growth %-2.95%-23.14%0.79%-0.07%
EPS (Basic)0.020.09-2.07-0.37-0.47
Diluted Shares Outstanding7.42M9.25M12.03M22.9M32.46M
Basic Shares Outstanding7.42M9.25M12.03M27.25M32.46M
Dividend Payout Ratio-----

Balance Sheet

Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+4.27M4.35M25.03M723.44K762.88K
Cash & Short-Term Investments250.77K190K57.54K189K237.6K
Cash Only250.77K190K57.54K189K237.6K
Short-Term Investments00000
Accounts Receivable1.61M4.09M192.85K239.19K170.27K
Days Sales Outstanding66.41327.3518.723.5515.49
Inventory00648.16K0128.98K
Days Inventory Outstanding--81.74-14.49
Other Current Assets2.35M2.8K24.12M295.25K226.03K
Total Non-Current Assets+1.61M3.65M602.56K587.07K967.34K
Property, Plant & Equipment137.41K161.16K124.5K206.99K316.26K
Fixed Asset Turnover64.59x28.29x30.24x17.91x12.68x
Goodwill1.01M992.69K000
Intangible Assets461.29K289.96K00337.3K
Long-Term Investments02.2M000
Other Non-Current Assets02.2M478.06K380.07K281.38K
Total Assets+5.88M8M25.63M1.31M1.73M
Asset Turnover1.51x0.57x0.15x2.83x2.32x
Asset Growth %-0.36%2.2%-0.95%0.32%
Total Current Liabilities+6.09M7.32M29.12M8.72M4.14M
Accounts Payable1.48M2.82M1.46M1.29K25.89K
Days Payables Outstanding108.13311.01184.30.162.91
Short-Term Debt657.17K353.73K3.57M3.17M1.04M
Deferred Revenue (Current)00-1000K0477.92K
Other Current Liabilities3.46M3.82M25.14M4.6M-624
Current Ratio0.70x0.59x0.86x0.08x0.18x
Quick Ratio0.70x0.59x0.84x0.08x0.15x
Cash Conversion Cycle---83.87-27.08
Total Non-Current Liabilities+104.3K82.95K15.02K75.11K160.91K
Long-Term Debt00000
Capital Lease Obligations25.88K33.65K15.02K75.11K51.8K
Deferred Tax Liabilities049.29K0076.7K
Other Non-Current Liabilities78.42K00032.4K
Total Liabilities6.2M7.4M29.14M8.79M4.3M
Total Debt+709.97K462.31K3.63M3.37M1.27M
Net Debt459.2K272.31K3.57M3.19M1.03M
Debt / Equity-0.77x---
Debt / EBITDA-----
Net Debt / EBITDA-----
Interest Coverage-13.58x-4.41x-60.98x-170.55x-386.17x
Total Equity+-317.36K600.05K-3.51M-7.48M-2.57M
Equity Growth %-2.89%-6.84%-1.13%0.66%
Book Value per Share-0.040.06-0.29-0.33-0.08
Total Shareholders' Equity-360.59K521.23K-3.52M-7.5M-2.55M
Common Stock334.86K334.86K21.31M27.43M47.81M
Retained Earnings-684.5K180.33K-24.7M-34.74M-50.1M
Treasury Stock00000
Accumulated OCI-10.96K6.04K-125.69K-185.47K-260K
Minority Interest43.23K78.82K13.48K16.61K-19.01K

Cash Flow

Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+-411.88K443.92K-1.53M-2.92M-2.03M
Operating CF Margin %-0.05%0.1%-0.41%-0.79%-0.51%
Operating CF Growth %-2.08%-4.44%-0.91%0.3%
Net Income198.97K900.4K-24.95M-8.44M-17.6M
Depreciation & Amortization285.38K264.1K172.02K119.35K173.22K
Stock-Based Compensation00000
Deferred Taxes-32.27K-27.68K-48.23K0-4.38K
Other Non-Cash Items-85.21K-1.87M22.18M4.87M15.21M
Working Capital Changes-778.75K1.18M1.12M531.2K194.93K
Change in Receivables735.82K-263.95K-174.82K-32.97K82.35K
Change in Inventory003.69M0-126.27K
Change in Payables-791.25K1.38M-1.13M1.27K15.99K
Cash from Investing+179.34K-356.18K-268.21K0-147.77K
Capital Expenditures-76.06K-1.96K-18.14K-5-116.03K
CapEx % of Revenue0.01%0%0%0%0.03%
Acquisitions-----
Investments-----
Other Investing00-246.66K5-48.03K
Cash from Financing+212.51K-168.37K2.49M2.35M2.32M
Debt Issued (Net)-----
Equity Issued (Net)-----
Dividends Paid00000
Share Repurchases-----
Other Financing182.52K-161.69K-9.47K121.88K115.14K
Net Change in Cash-----
Free Cash Flow+-487.94K441.96K-1.54M-2.92M-2.15M
FCF Margin %-0.05%0.1%-0.41%-0.79%-0.54%
FCF Growth %-1.91%-4.5%-0.89%0.26%
FCF per Share-0.070.05-0.13-0.13-0.07
FCF Conversion (FCF/Net Income)-2.35x0.51x0.06x0.29x0.13x
Interest Paid66.19K110.83K19.59K17.52K55.38K
Taxes Paid12.58K30.18K156.34K42.9K11.63K

Key Ratios

Metric20202021202220232024
Return on Equity (ROE)-611.85%---
Return on Invested Capital (ROIC)-472.47%-82.82%-913.9%--
Gross Margin43.83%27.42%23.11%22.72%19%
Net Margin1.98%18.97%-661.06%-270.86%-382.87%
Debt / Equity-0.77x---
Interest Coverage-13.58x-4.41x-60.98x-170.55x-386.17x
FCF Conversion-2.35x0.51x0.06x0.29x0.13x
Revenue Growth--48.64%-17.42%-1.54%8.22%

Revenue by Segment

202220232024
Property Management Services3.76M3.71M3.92M
Property Management Services Growth--1.54%5.81%
Product Sales--89.02K
Product Sales Growth---
Medical Service6.08M--
Medical Service Growth---

Revenue by Geography

202220232024
Property Management Services--3.92M
Property Management Services Growth---
Product Sales--89.02K
Product Sales Growth---

Frequently Asked Questions

Growth & Financials

EUDA Health Holdings Limited (EUDA) reported $5.2M in revenue for fiscal year 2024. This represents a 42% decrease from $8.9M in 2020.

EUDA Health Holdings Limited (EUDA) grew revenue by 8.2% over the past year. This is steady growth.

Yes, EUDA Health Holdings Limited (EUDA) is profitable, generating $0.3M in net income for fiscal year 2024 (-382.9% net margin).

Dividend & Returns

EUDA Health Holdings Limited (EUDA) had negative free cash flow of $2.1M in fiscal year 2024, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.